Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Dr5 Antibody
NCTP01389
Description: Rabbit polyclonal to human Dr5
Application: ELISA, WB, IHC
Reactivity: Human, rat, mouse
Catalog #: NCTP01389
$380
1000 Items
Overview
| DESCRIPTION | |
| Species Reactivity | Human, rat, mouse. Other species not tested. |
| Isotype | IgG |
| Immunogen | A peptide from the middle region of human dr5 |
| Accession # | O14763 |
| Alternative Names | Tumor necrosis factor receptor superfamily member 10B; Death receptor 5; TRAIL receptor 2; TRAIL-R2; CD_antigen: CD262; TNFRSF10B; KILLER; TRAILR2; TRICK2; ZTNFR9 |
| Purification | Purified by peptide affinity column. |
| Formulation | Lyophilized with 2% BSA and 0.02% NaN3. |
| Size | 100µg/200µl |
| APPLICATION | |
| ELISA | 1:5,000-1:10,000 |
| Western Blot | 1:200-1:1,000 |
| Immunohistochemistry | 1:50-1:200 |
| - | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
| PREPARATION AND STORAGE | |
| Reconstitution | Reconstitute in 200µl of sterile H2O. |
| Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
| REFERENCES | |
| - | Day, T.W., Huang, S. and Safa, A.R., c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells. Biochem. Pharmacol. 76 (12), 1694-1704 (2008). |